Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA)

Behavioural Pharmacology

Volumn 16, Issue 2, 2005, Pages 127-130

  Bubeníková, Vera ^a   Votava, M ^a,b   Horacek J ^a   Palenicek T ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Estrous cycle; MDMA; PPI; Rats; Sex differences

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIESTRUS; DRUG EFFECT; DRUG MECHANISM; ESTRUS CYCLE; FEMALE; MALE; METESTRUS; NONHUMAN; PREPULSE INHIBITION; PROESTRUS; RAT; SENSORIMOTOR FUNCTION; SEROTONIN RELEASE; SEX; SEX DIFFERENCE; STARTLE REFLEX;

EID: 16444365418     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200503000-00009     Document Type: Article

References (24)

1. Bankson MG, Cunningham KA (2001). 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interaction. J Pharmacol Exp Ther 297:846-852.
2. Burgess C, O'Donohoe A, Gill M (2000). Agony and ecstasy: a review of MDMA effects and toxicity. Europ Psychiatry 15:287-294.
3. Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F, et al. (2004). Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine(1 A) receptors. Neuroscience 127:261-267.
4. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP (2004). Sex and estrogen influence drug abuse. Trends Pharmacol Sci 25:273-279.
5. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154.
6. Gogos A, Van den Buuse M (2004). Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1 A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309:267-274.
7. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Pharmacol Rev 55:463-508.
8. Gundlah C, Simon LD, Auerbach SB (1998). Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain Res 785:91-96.
9. Koch M (1999). The neurobiology of startle. Prog Neurobiol 58:107-128.
10. Marcondes FK, Bianchi FJ, Tanno AP (2002). Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62:609-614.
11. McEwen B (2002). Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384.
12. McQueen JK, Wilson H, Sumner BEH, Fink G (1999). Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Mol Brain Res 63:241-247.
13. Ramirez OA, Carrer HF (1982). Effect of estrogen and progesterone priming on the uptake and release of serotonin and noradrenaline from the ventromedial hypothalamus. Acta Physiol Lat Am 32:313-319.
14. Rothman RB, Baumann MH (2002). Therapeutic and averse actions of serotonin transporter substrates. Pharmacol Ther 95:73-78.
15. Schulz B, Fendt M, Pedersen V, Koch M (2001). Sensitization of prepulse Inhibition deficits by repeated administration of dizocilpine. Psychopharmacology (Berl) 156:177-181.
16. Simantov R (2004). Multiple molecular and neuropharmacological effects of MDMA (Ecstasy). Life Sci 74:803-814.
17. Sipes TA, Geyer MA (1994). Multiple serotonin receptor subtypes modulate prepulse inhibition, of the startle response in rats. Neuropharmacology 33:441-448.
18. Sipes TA, Geyer MA (1995). 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology (Berl) 117:41-48.
19. Sipes TE, Geyer MA (1997). DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Res 27:97-104.
20. Spornitz UM, Socin SD, Dravid AA (1999). Estrous stage determination in rats by means of scanning electron microscopic images of uterine surface epithelium. Anat Rec 254:116-126.
21. Swerdlow NR, Caine SB, Geyer MA (1992). Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 108:189-195.
22. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156:194-215.
23. Vollenweider FX, Remensberger S, Hell D, Geyer MA (1999). Oposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology (Berl) 143:365-372.
24. Yamamoto BK, Nash JF, Geudlesky GA (1995). Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and γ-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther 273:1063-1070.